MX354498B - Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. - Google Patents

Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.

Info

Publication number
MX354498B
MX354498B MX2014003638A MX2014003638A MX354498B MX 354498 B MX354498 B MX 354498B MX 2014003638 A MX2014003638 A MX 2014003638A MX 2014003638 A MX2014003638 A MX 2014003638A MX 354498 B MX354498 B MX 354498B
Authority
MX
Mexico
Prior art keywords
imidazole
hydroxy
carboxamide
hydrate
crystal
Prior art date
Application number
MX2014003638A
Other languages
English (en)
Spanish (es)
Other versions
MX2014003638A (es
Inventor
Fujimoto Taisuke
Hashimoto Tomohiro
Hayashi Katsuyuki
Tanaka Tomoyuki
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of MX2014003638A publication Critical patent/MX2014003638A/es
Publication of MX354498B publication Critical patent/MX354498B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MX2014003638A 2011-09-28 2012-09-28 Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. MX354498B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011213501 2011-09-28
JP2011213500 2011-09-28
PCT/JP2012/075106 WO2013047758A1 (ja) 2011-09-28 2012-09-28 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド水和物の結晶及び５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の結晶及びその製造方法

Publications (2)

Publication Number Publication Date
MX2014003638A MX2014003638A (es) 2014-05-21
MX354498B true MX354498B (es) 2018-03-08

Family

ID=47995783

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003638A MX354498B (es) 2011-09-28 2012-09-28 Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.

Country Status (13)

Country Link
US (2) US9108928B2 (enExample)
EP (1) EP2762469B1 (enExample)
KR (1) KR101970509B1 (enExample)
CN (1) CN103827093B (enExample)
AU (1) AU2012317424B2 (enExample)
BR (1) BR112014007436A2 (enExample)
CA (1) CA2850196A1 (enExample)
IL (2) IL231677A (enExample)
IN (1) IN2014CN02346A (enExample)
MX (1) MX354498B (enExample)
RU (2) RU2630682C2 (enExample)
SG (1) SG11201400974VA (enExample)
WO (1) WO2013047758A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013047758A1 (ja) 2011-09-28 2013-04-04 富士フイルム株式会社 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド水和物の結晶及び５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の結晶及びその製造方法
EP2947069B1 (en) * 2013-01-15 2017-11-22 FUJIFILM Corporation Sulfate of 5-hydroxy-1h-imidazole-4-carboxamide
EP3093662B1 (en) 2014-01-10 2019-05-15 Fujifilm Corporation 5-hydroxy-1h-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
JP6823660B2 (ja) * 2016-09-13 2021-02-03 富士フイルム株式会社 Ｍｌｌ関連白血病の予防または治療のための医薬、方法、使用及び化合物
EP3686189B1 (en) 2017-10-27 2021-09-01 FUJIFILM Corporation Production method for 5-hydroxy-1h-imidazole-4-carboxamide-3/4hydrate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181731A (en) * 1976-09-07 1980-01-01 Sumitomo Chemical Company, Limited Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
JPS5625165A (en) * 1979-08-08 1981-03-10 Sumitomo Chem Co Ltd Novel imidazole derivative
JPS5824569A (ja) * 1981-08-05 1983-02-14 Sumitomo Chem Co Ltd イミダゾ−ル誘導体の精製方法
US4503235A (en) * 1983-03-11 1985-03-05 Warner-Lambert Company Process for producing 4-carbamoyl-1H-imidazolium-5-olate
JPS60185727A (ja) * 1984-03-05 1985-09-21 Sumitomo Chem Co Ltd ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
US5567816A (en) 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
CA2152863A1 (en) 1994-07-26 1996-01-27 Yeun-Kwei Han Preparation of acyclovir
BR0114202A (pt) 2000-09-29 2003-10-07 Basf Ag Processos para a preparação de 5-cloro-4-metilpirazóis 1-substituìdos, e, para a preparação de pirazolonas 1-substituìdas
JP2002265601A (ja) 2001-03-07 2002-09-18 Rikogaku Shinkokai イミド樹脂
BRPI0607439A2 (pt) * 2005-02-16 2010-04-06 Solvay Pharm Bv compostos, composição farmacêutica, método de preparação de composições farmacêuticas, e, uso de um composto
UA94737C2 (ru) * 2006-02-24 2011-06-10 Лексикон Фармасьютикалз, Инк. Соединения на основе имидазола, композиция, которая их содержит, и их применение
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
KR100982720B1 (ko) * 2008-02-04 2010-09-17 주식회사 파마코스텍 4-카르바모일-1-β-Ｄ-리보푸라노실이미다졸륨-5-올레이트의 생산을 위한 중간체로서의 2-아미노말론아미드의제조방법
TWI573791B (zh) 2011-09-28 2017-03-11 富士軟片股份有限公司 ５－羥基－１ｈ－咪唑－４－甲醯胺．３／４水合物及其結晶之製造方法
WO2013047758A1 (ja) 2011-09-28 2013-04-04 富士フイルム株式会社 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド水和物の結晶及び５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の結晶及びその製造方法

Also Published As

Publication number Publication date
CN103827093B (zh) 2016-06-15
US20150315156A1 (en) 2015-11-05
IL231677A0 (en) 2014-05-28
BR112014007436A2 (pt) 2017-04-04
RU2014111810A (ru) 2015-11-10
RU2630682C2 (ru) 2017-09-12
CN103827093A (zh) 2014-05-28
AU2012317424A8 (en) 2014-07-03
SG11201400974VA (en) 2014-09-26
IL231677A (en) 2017-01-31
AU2012317424A1 (en) 2014-04-17
CA2850196A1 (en) 2013-04-04
US9108928B2 (en) 2015-08-18
IN2014CN02346A (enExample) 2015-06-19
NZ622928A (en) 2015-04-24
RU2672560C1 (ru) 2018-11-16
HK1197406A1 (zh) 2015-01-16
EP2762469A4 (en) 2015-01-14
IL246754A (en) 2017-08-31
EP2762469A1 (en) 2014-08-06
US20140275568A1 (en) 2014-09-18
MX2014003638A (es) 2014-05-21
KR101970509B1 (ko) 2019-04-19
KR20140069052A (ko) 2014-06-09
AU2012317424B2 (en) 2017-05-18
EP2762469B1 (en) 2016-11-23
US9567303B2 (en) 2017-02-14
WO2013047758A1 (ja) 2013-04-04

Similar Documents

Publication Publication Date Title
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
UA116876C2 (uk) Спосіб одержання хінолінових похідних
PH12016502334B1 (en) Method for producing fused heterocyclic compound
NZ718009A (en) Process for producing diazabicyclooctane derivative and intermediate thereof
WO2014026657A3 (en) A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates
EP3560929A3 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
MX2014003638A (es) Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.
IN2012DN01104A (enExample)
MX347564B (es) Proceso para la preparacion de n-metoxi-[1-metil-2-feniletil]amida s del acido 3-difluorometil-1-metil-1h-pirazol-4-carboxilico sustituidas con fenilo.
IN2014DN00144A (enExample)
WO2012099734A3 (en) Improved process for preparation of low molecular weight molybdenum succinimide complexes
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
EA201270237A1 (ru) Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
TN2014000329A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
IN2015DN02241A (enExample)
MX361998B (es) Procedimiento de preparacion de derivados de acido 4-haloalquil-3-mercapto-2 sustituido-hidroxibenzoico.
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
UA113067C2 (xx) Спосіб одержання хінолінкарбонової кислоти
EA201300100A2 (ru) Способ ферментативного синтеза (7s)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбоновой кислоты или ее сложных эфиров и применение для синтеза ивабрадина и его соли
UA102091C2 (ru) Способ получения сульфонилпиролов как ингибиторов hdac
SA112330994B1 (ar) عملية جديدة لتخليق إيفابردين وأملاح الإضافة الخاصة به مع حمض مقبول صيدلانياً
MX369283B (es) Preparacion de 2-amino-5-ciano-n, 3-dimetilbenzamida.

Legal Events

Date Code Title Description
FG Grant or registration